INCY
INCY
INCY
Ahead of the announcement that Incyte will report its third quarter financial results, the company holds a market capitalization of approximately 25.69 billion USD. Incyte shows a trailing twelve months EPS of 8.05 alongside a PE ratio of 15.59, with annual revenue standing at 5.14 billion USD. Additionally, the company currently maintains a free cash flow yield of 7.47%.
Based on gurufocus.comIncyte Honors the 2026 MPN Heroes®, Celebrating Champions of the Myeloproliferative Neoplasm (MPN) Community
Incyte to Report Third Quarter Financial Results
Incyte to Report Third Quarter Financial Results
Knight Therapeutics Announces Regulatory Approval of NIKTIMVO® in Brazil
INCY or TECH: Which Is the Better Value Stock Right Now?
MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Blinx with professional market data, charts beside chat, and your portfolio context.
Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.